Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Evotec SE

www.evotec.com

Latest From Evotec SE

Biocon Agrees Biosimilar Partnership With Evotec

Biocon and Evotec have struck a licensing deal that will allow Biocon to expand its current basket of biosimilars beyond diabetes, oncology and immunology, in exchange for licensing and milestone payments to Evotec.

Deals Biosimilars

Finance Watch: 3Q Biopharma Venture Capital Financings Fell From 2Q Spike

VC deals totaled $8.3bn in the first half of 2019, but the year's total rose to just $11.5bn at the end of September, reflecting only a $3.2bn third quarter gain. Among recent financings, Cygnal emerged from stealth mode with $65m invested to date.

Financing StartUps and SMEs

Promising Shionogi Candidate Moves Ahead In Gram-Negative Pneumonia

Novel Shionogi antibiotic candidate set to move ahead following positive results in Gram-negative pneumonia, where resistance and unmet needs remain critical factors.
Infectious Diseases Clinical Trials

Deal Watch: Another Delay For Roche/Spark, While FTC Ups AbbVie/Allergan Merger Scrutiny

Tender deadline for Roche acquisition of Spark pushed back to 30 October; 21.4% of Spark shares tendered so far. Vertex further diversifies with fourth deal of 2019 – an RNA-targeted collaboration with Ribometrix.

Deals M & A
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register